Novel marker D2‐40, combined with calretinin, CEA, and TTF‐1

Takeshi Mimura(Kobe City Nishi-Kobe Medical Center), Morihito Okada(The University of Osaka), Chiho Ohbayashi(Hyogo Prefectural Cancer Center), Akihiko Ito(The University of Tokyo), Toshiko Sakuma(Hyogo Prefectural Cancer Center), Yutaka Okita(Takatsuki General Hospital), Noriaki Tsubota(Akashi Medical Center), Masahiro Yoshimura(Hyogo Prefectural Cancer Center)
Cancer
February 5, 2007
Cited by 50


Related Papers